Mengzhen Li

1.5k total citations
58 papers, 686 citations indexed

About

Mengzhen Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mengzhen Li has authored 58 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Mengzhen Li's work include Cancer-related molecular mechanisms research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and RNA modifications and cancer (4 papers). Mengzhen Li is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and RNA modifications and cancer (4 papers). Mengzhen Li collaborates with scholars based in China, United States and United Kingdom. Mengzhen Li's co-authors include Zhangwei Tong, Chundong Yu, Bing Shen, Kesong Peng, Jun Yan, Liping Qin, Shangwu Chen, Lian‐Wen Qi, Shujun Jiang and Yizhuo Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Analytical Chemistry.

In The Last Decade

Mengzhen Li

53 papers receiving 681 citations

Peers

Mengzhen Li
Mengzhen Li
Citations per year, relative to Mengzhen Li Mengzhen Li (= 1×) peers İbrahim Tekedereli

Countries citing papers authored by Mengzhen Li

Since Specialization
Citations

This map shows the geographic impact of Mengzhen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhen Li more than expected).

Fields of papers citing papers by Mengzhen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhen Li. The network helps show where Mengzhen Li may publish in the future.

Co-authorship network of co-authors of Mengzhen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhen Li. A scholar is included among the top collaborators of Mengzhen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhen Li. Mengzhen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Lei, Mengzhen Li, Juan Wang, et al.. (2025). Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China. Frontiers in Immunology. 16. 1608844–1608844.
2.
Zhu, Jianshu, Mengzhen Li, Mingshui Zhao, et al.. (2025). OsSEC3A , a key exocyst subunit, is required for the emergence of crown root in rice. New Phytologist. 249(2). 917–929.
3.
Li, Mengzhen, et al.. (2024). Design, synthesis and biological evaluation of galantamine analogues for cognitive improvement in Alzheimer's disease. European Journal of Medicinal Chemistry. 284. 117198–117198. 3 indexed citations
4.
Wang, Shiyang, Mengzhen Li, Manyu Song, et al.. (2024). m6A Reader PRRC2A Promotes Colorectal Cancer Progression via CK1ε‐Mediated Activation of WNT and YAP Signaling Pathways. Advanced Science. 12(3). e2406935–e2406935. 3 indexed citations
5.
Zhu, Jianshu, Mengzhen Li, Hong Lu, et al.. (2024). The t‐SNARE protein OsSYP132 is required for vesicle fusion and root morphogenesis in rice. New Phytologist. 244(6). 2413–2429. 1 indexed citations
6.
Zhang, Ruiwen, Mengzhen Li, Yaoyang Liu, et al.. (2024). Near-infrared fluorescent probes for imaging of amyloid-β at different stages in monitoring Alzheimer's disease. Dyes and Pigments. 224. 111993–111993. 7 indexed citations
7.
Cheng, Liang, Ping Wang, Mengzhen Li, et al.. (2024). Anti-cancer mechanisms of natural isoflavones against melanoma. Heliyon. 10(7). e28616–e28616. 6 indexed citations
8.
Peng, Wenlong, et al.. (2024). The differentiated adoption of green planting technology by farmers and its influencing factors: the case from Juxian County, China. Environment Development and Sustainability. 2 indexed citations
9.
Li, Mengzhen, Hanxun Wang, Yaoyang Liu, et al.. (2024). Potential oral VEGFR2 inhibitors: Treatment of wet age-related macular degeneration. Bioorganic Chemistry. 144. 107110–107110. 2 indexed citations
10.
Li, Mengzhen, Yang Hu, Yanjie Xu, et al.. (2023). The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma. International Journal of Oncology. 64(2). 8 indexed citations
11.
Wang, Zhipeng, Pengyu Li, Yiran Li, et al.. (2023). Identification of quiescent FOXC2+ spermatogonial stem cells in adult mammals. eLife. 12. 8 indexed citations
12.
Deng, Min, Christian F. Guerrero‐Juarez, Xiaole Sheng, et al.. (2022). Lepr+ mesenchymal cells sense diet to modulate intestinal stem/progenitor cells via Leptin–Igf1 axis. Cell Research. 32(7). 670–686. 23 indexed citations
13.
Sun, Chengtao, Mengzhen Li, Feifei Sun, et al.. (2022). IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma. Cell Death and Disease. 13(6). 572–572. 18 indexed citations
14.
Liu, Ping, Hui Li, Yuling Tang, et al.. (2022). Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. PeerJ. 10. e12731–e12731. 8 indexed citations
15.
Gharizadeh, Baback, Mengzhen Li, Jorge Basiletti, et al.. (2022). A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections. Infectious Agents and Cancer. 17(1). 9–9. 6 indexed citations
16.
Sun, Chengtao, Mengzhen Li, Yanfen Feng, et al.. (2020). <p>MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma</p>. OncoTargets and Therapy. Volume 13. 10475–10487. 13 indexed citations
17.
Chen, Shuang, Mengzhen Li, Wei Jiang, et al.. (2020). The role of Neu1 in the protective effect of dipsacoside B on acetaminophen-induced liver injury. Annals of Translational Medicine. 8(13). 823–823. 19 indexed citations
18.
Peng, Kesong, Mengzhen Li, Liping Qin, et al.. (2017). Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α. Oncogene. 36(27). 3868–3877. 90 indexed citations
19.
Li, Yuxin, Yu Sun, Yonggui Fu, et al.. (2012). Dynamic landscape of tandem 3′ UTRs during zebrafish development. Genome Research. 22(10). 1899–1906. 55 indexed citations
20.
Yu, Li, Mian He, Zheng Yang, et al.. (2011). Olfactomedin 4 Is a Marker for Progression of Cervical Neoplasia. International Journal of Gynecological Cancer. 21(2). 367–372. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026